ICD-10-CM · Multi-region

M05.59

Rheumatoid polyneuropathy with seropositive (rheumatoid factor–positive) rheumatoid arthritis affecting multiple joint sites simultaneously.

Verified May 8, 2026 · 5 sources ↓

Status
Billable
Chapter
13
Related CPT
5
Region
Multi-region
Drawn from CDCICD10DataAAPCRhinomdsHealth

Documentation tips

What should appear in the chart to support M05.59.

Source · Editorial brief grounded in 5 cited references ↓

  • Document positive rheumatoid factor (RF) or anti-CCP lab result explicitly — M05 codes require seropositive status and payers may deny without lab evidence in the record.
  • Name each affected joint site or use language such as 'polyarticular involvement' to support the 'multiple sites' designation and justify M05.59 over a site-specific M05.5x code.
  • Record the neurological findings — numbness, tingling, weakness, sensory loss, abnormal EMG/NCS — that substantiate the polyneuropathy component as a systemic RA manifestation.
  • Note current disease-modifying or biologic therapy (e.g., methotrexate, TNF inhibitor) in the assessment; this supports medical necessity for ongoing management and risk-adjustment coding.
  • If imaging or joint aspiration supports active synovitis at multiple sites, include those findings to reinforce polyarticular disease documentation.

Related CPT procedures

Procedure codes commonly billed with M05.59. Linking the right diagnosis to the right procedure is what establishes medical necessity.

Source · CMS LCDs · AAOS specialty guidance · claims-pattern analysis

Common coding pitfalls

The recurring mistakes coders make with M05.59 and adjacent codes.

Source · Editorial brief grounded in CDC ICD-10-CM tabular guidance, AAOS coding references, and cited references ↓

  • Using M05.59 when only one joint site is involved — if a single site dominates, use the corresponding laterality-specific M05.5x code (e.g., M05.561 for right knee) instead.
  • Assigning M05.59 without documented seropositivity — if RF and anti-CCP are negative or not tested, M06 codes are appropriate; M05 requires confirmed rheumatoid factor positivity.
  • Adding a separate peripheral neuropathy code (e.g., G62.9) when the polyneuropathy is explicitly documented as a rheumatoid manifestation — the complication is already captured in M05.59.
  • Confusing M05.59 (polyneuropathy, multiple sites) with M05.79 (rheumatoid arthritis with rheumatoid factor, multiple sites, without organ/system involvement) — M05.59 requires the neurological complication to be documented.
  • Defaulting to M05.9 (unspecified) when the record clearly documents neuropathy and polyarticular disease — that level of specificity makes M05.59 the correct and more complete code.

Clinical context

Source · Editorial summary grounded in 5 cited references ↓

M05.59 applies when a patient with confirmed rheumatoid factor–positive rheumatoid arthritis develops peripheral polyneuropathy as a recognized systemic complication, and the joint involvement spans multiple sites (e.g., bilateral hands, wrists, knees, or feet together). The '9' sixth character signals multiple sites rather than a single named joint — use this code only when the clinical record documents polyarticular disease, not a single isolated joint with neuropathic changes.

Within the M05.5x family, site-specific codes exist for shoulder (M05.51x), elbow (M05.52x), wrist (M05.53x), hand (M05.54x), hip (M05.55x), knee (M05.56x), and ankle/foot (M05.57x), each with right (1), left (2), and unspecified (9) laterality options. M05.59 is the correct choice only when the provider explicitly documents involvement at multiple sites or the disease is polyarticular and no single dominant site is specified.

Because M05.59 sits under M05 (Rheumatoid arthritis with rheumatoid factor), seropositivity must be reflected in the record — a positive RF or anti-CCP lab result documented by the treating clinician. If seropositivity is not established, consider M06 codes for seronegative or other rheumatoid arthritis. The neuropathy here is the rheumatoid polyneuropathy that is a systemic manifestation of the RA itself, not a separate peripheral neuropathy from another etiology; do not stack an additional neuropathy code unless a distinct, separately documented neuropathic etiology exists.

Sibling codes

Other billable codes under M05.5 (laterality / anatomic variants).

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 5 cited references ↓

01Does M05.59 require a positive rheumatoid factor lab result?
Yes. All M05 codes — including M05.59 — apply only to seropositive RA. The treating provider must document a positive RF or anti-CCP result. Without it, use M06 codes for seronegative or other rheumatoid arthritis.
02When should I use M05.59 instead of a site-specific M05.5x code?
Use M05.59 when the clinical documentation describes polyarticular involvement at multiple named sites. If the encounter focuses on a single joint — for example, just the right knee — use M05.561 instead. The 'multiple sites' designation must reflect what the provider actually documented.
03Should I code the polyneuropathy separately with a G-code?
No — when the polyneuropathy is documented as a manifestation of rheumatoid arthritis, M05.59 captures both the RA and the neuropathic complication. Add a separate neuropathy code only if a distinct, independently documented neuropathic etiology is present.
04What is the difference between M05.59 and M05.79?
M05.59 specifies rheumatoid polyneuropathy as a systemic complication at multiple sites. M05.79 codes seropositive RA at multiple sites without organ or system involvement. The key distinction is whether neurological complication is documented — if it is, M05.59 is correct.
05Can M05.59 be used as a primary diagnosis for an orthopedic encounter?
Yes, it is a billable code and can serve as the principal diagnosis when the encounter addresses the polyarticular RA with polyneuropathy. In an orthopedic setting, it commonly accompanies joint management, physical therapy, or surgical planning for RA-related joint destruction.
06Is M05.59 appropriate when only bilateral hands and wrists are involved?
If bilateral hands and wrists are the documented sites and polyneuropathy is confirmed, M05.59 is defensible as multiple sites. However, if the record is specific enough to code each side individually using site-specific codes, those more granular codes may be preferred by your payer for maximum specificity.
07Does M05.59 have 7th-character extension requirements?
No. M05.59 is an M-code (chronic musculoskeletal condition), not an injury S-code. Seventh-character extensions (A, D, S) do not apply. The code is complete as a six-character code.

Mira AI Scribe

Mira AI Scribe captures the RF/anti-CCP lab positivity, the named joint sites involved (bilateral or multiple), and the specific neurological symptoms (e.g., distal sensory loss, paresthesias) or EMG/NCS findings that confirm polyneuropathy as a systemic RA complication. That documentation prevents the claim from being downcoded to unspecified M05.9 or denied for missing evidence of both the neuropathic manifestation and polyarticular involvement.

See how Mira captures M05.59 documentation

Related ICD-10 codes

Ready?

Ready to transform your orthopedic practice?

See how orthopedic practices are running documentation, billing, and operations on a single voice-first platform.

Get started for free